Communiqués MedCap AB

Actions

Marché Fermé - Nasdaq Stockholm 18:00:00 08/10/2026			Varia. 5j.	Varia. 1 janv.
503,50 ^SEK	-1,95%		-1,95%	-8,29%

01/10	Medcap nomme Johan Boqvist à la tête de l’activité Technologies médicales	FW
01/10	Medcap nomme un nouveau responsable des technologies médicales	FW

26/07	MedCap (Q2 Review): Broad-Based Beat	AQ
21/07	MedCap : Strong growth - adjusted EBITA increased by 28 percent	PU
26/06	MedCap AB (publ) has signed an agreement to acquire Biopsafe ApS in Denmark.	AQ
05/05	MedCap (Q1 review): Strong EBITA Growth, Poised for Acquisitions	AQ
29/04	MedCap : Presentation Q1 2026	PU
06/03	MedCap : RedEye Serial Acquirers Conference	PU
06/03	MedCap : Danske Bank Small & Midcap Seminar	PU
11/02	MedCap (Q4 review): Beat on Solid Organic Growth	AQ
06/02	MedCap : Year-end Report Q4 2025	PU
06/02	MedCap : Year-end Report Q4 2025 Presentation	PU
07/01	MedCap : SEB Nordic Seminar	PU
27/10/25	MedCap (Q3 review) - Healthy Q3 figures	AQ
24/10/25	Strong organic and acquired growth; EBITA increased by 32%	AQ
01/10/25	Abilia acquires LivAssured	AQ
23/07/25	MedCap Q2 2025 - The rise, fall, and rise again	AQ
23/07/25	Strong quarter with 20 percent EBITA growth and acquisition in Specialty Pharma	AQ
21/07/25	MedCap's Business Area Specialty Pharma Completes the Acquisition of XGX Pharma	AQ
25/06/25	MedCap's Business Area Specialty Pharma Acquires XGX Pharma	AQ
30/04/25	MedCap Q1 2025 - Step by step	AQ
29/04/25	7% growth and EBITA margin recovers to 17%	AQ
03/02/25	MedCap Q4 2024 - A tale of euphoria and despair	AQ
31/01/25	MedCap : Presentation MedCap Q4 2024	PU
31/01/25	Good demand but unsatisfactory earnings. Strong cash flow.	AQ
31/01/25	MedCap's Business Area Assistive Tech Acquires Danrehab	AQ
16/01/25	Preliminary result for the fourth quarter	AQ